Merck-min - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Merck acquires VelosBio: exploring the promise of ROR1 in cancer

Merck-min
Merck has acquired VelosBio for $2.75bn. Credit: Merck.